CL2010000548A1 -
Pharmaceutical compound because it contains a peptide; pharmaceutical composition that includes it; use of the pharmaceutical composition to stimulate hematopoiesis.
- Google Patents
Pharmaceutical compound because it contains a peptide; pharmaceutical composition that includes it; use of the pharmaceutical composition to stimulate hematopoiesis.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=66220936&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010000548(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunotech Dev IncfiledCriticalImmunotech Dev Inc
Priority to CL2010000548ApriorityCriticalpatent/CL2010000548A1/en
Publication of CL2010000548A1publicationCriticalpatent/CL2010000548A1/en
Compuesto farmacéutico porque contiene un péptido; composición farmacéutica que lo comprende; uso de la composición farmacéutica para estimular la hematopoyesis.Pharmaceutical compound because it contains a peptide; pharmaceutical composition comprising it; use of the pharmaceutical composition to stimulate hematopoiesis.
CL2010000548A2010-05-262010-05-26
Pharmaceutical compound because it contains a peptide; pharmaceutical composition that includes it; use of the pharmaceutical composition to stimulate hematopoiesis.
CL2010000548A1
(en)
Pharmaceutical compound because it contains a peptide; pharmaceutical composition that includes it; use of the pharmaceutical composition to stimulate hematopoiesis.
Pharmaceutical compound because it contains a peptide; pharmaceutical composition that includes it; use of the pharmaceutical composition to stimulate hematopoiesis.
Pharmaceutical compound because it contains a peptide; pharmaceutical composition that includes it; use of the pharmaceutical composition to stimulate hematopoiesis.
Antibody that binds to human r-spondin 1 (rspo1); polypeptide comprising an antibody; pharmaceutical composition comprising the antibody; use to inhibit the growth of a tumor.
Use of specific sgc stimulating and / or activating compounds; pharmaceutical formulation comprising said compounds; kit comprising the compounds, and use for the prevention and / or treatment of systematic sclerosis.
Compounds derived from phenylamino-isonicotinamide; mek inhibitors; Pharmaceutical composition and use for the treatment of hyperproliferative diseases such as cancer and inflammation.
Compounds derived from substituted moropholinyl, useful as mogat-2 inhibitors; pharmaceutical composition that includes them; use in the treatment of hypertriglyceridemia.